Presenters
Endocrinologist, Division of Endocrinology & Metabolism
Prof. Alice Yuk-Yan Cheng, MD
Course Details
The aim of this webinar is to provide updates on the guidelines and clinical trials of linagliptin, particularly on efficacy and cardiovascular and renal safety across a broad range of T2D patients, and how it supports the simplicity of its use for these patients.
CPD Points: 1 Point
PRC Program No: PROG-2021-20808
How to Succeed in the Long Game of T2D: Keeping the Management Simple Course Outline
- Efficacy of Linagliptin across a broad range of patients
- Long-term cardiovascular and renal safety of Linagliptin in T2D patients with cardiovascular and renal disease (CARMELINA)
- Long-term cardiovascular safety of Linagliptin in early T2D patients with increased CV risk (CAROLINA)
- Simplicity of Linagliptin across a broad range of patients
- Course Evaluation